<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="71008">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02181387</url>
  </required_header>
  <id_info>
    <org_study_id>IRB 23934</org_study_id>
    <nct_id>NCT02181387</nct_id>
  </id_info>
  <brief_title>Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor?</brief_title>
  <official_title>Does Acetaminophen Reduce Neuraxial Analgesic Requirement During Labor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis is if administration of acetaminophen during labor will reduce the amount of
      neuraxial pain medication required for comfort. For the study, Acetaminophen or placebo
      capsules will be administered at the time of neuraxial analgesia placement and then
      administered every 6 hours until delivery. Overall consumption of neuraxial pain medication
      will be determined.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acetaminophen 1000 mg or placebo capsules will be administered at the time of neuraxial
      analgesia placement and continued every 6 hours until delivery. Vital signs, scores for
      pain, nausea, itching, and sleepiness will be also obtained. Evaluation of consumption of
      neuraxial analgesic medication will be included in the final analysis for the differences
      between the 2 groups
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    funding and compounding issues
  </why_stopped>
  <start_date type="Actual">September 5, 2013</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Participant, Care Provider, Investigator</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neuraxial Analgesic Drug consumption per hour</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>subject evaluated every 2 hours with the amount of neuraxial analgesia consumed during that time period. Study med administered up to 24 hours. labor analgesia continue until delivery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>rescue doses</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>the incidence, frequency and amount of rescue doses.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maternal temperature</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>changes in maternal temperature throughout labor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain scores</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>evaluation of pain scores at periodic time points throughout labor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>satisfaction with labor analgesia evaluated at end of study (labor).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">37</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1000 mg every 6 hours during labor up to maximum 3 doses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo capsule identical to the acetaminophen capsule will be administered every 6 hours to a maximum of 4 doses</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>administered every 6 hours by mouth up to 4 doses</description>
    <arm_group_label>acetaminophen</arm_group_label>
    <other_name>tylenol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;/= 18 years of age not allergic to study medications

        Exclusion Criteria:

          -  pre-eclampsia in labor AND with demonstrated significant abnormal liver enzyme
             function changes non-English speaking subjects
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter H Pan, MD, MSEE</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Forsyth Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 27, 2017</lastchanged_date>
  <firstreceived_date>March 27, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wake Forest University Health Sciences</investigator_affiliation>
    <investigator_full_name>Dr. Peter H. Pan, M.D., MSEE</investigator_full_name>
    <investigator_title>Professor, OB Anesthesia</investigator_title>
  </responsible_party>
  <keyword>labor pain</keyword>
  <keyword>acetaminophen</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Analgesics</mesh_term>
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
